Recruiting for a new clinical trial
The purpose of this study is to determine the best way to measure progression of CMT1A over time. This study is important to prepare for clinical trials.
For more information, please contact:
Beth Wood at University of Rochester: ElizabethP_Wood@URMC.Rochester.edu
Alexa Bacha at University of Iowa: firstname.lastname@example.org
The imperative research for the development of CMT treatments is dependent on the funding from organizations like us.
To support our efforts to accelerate treatments for CMT, please donate today.